The effects of extra virgin olive oil and canola oil on inflammatory markers and gastrointestinal symptoms in patients with ulcerative colitis

Eur J Clin Nutr. 2020 Jun;74(6):891-899. doi: 10.1038/s41430-019-0549-z. Epub 2020 Jan 3.

Abstract

Background/objectives: Ulcerative colitis (UC) is an immune-mediated disease that causes inflammation in the gastrointestinal tract. Diet has an important role in the treatment of UC. This study aimed to compare the effects of extra virgin olive oil (EVOO), as a functional food, with canola oil in the treatment of UC.

Subjects/methods: Forty patients were participating in this crossover clinical trial. Thirty two patients completed two intervention rounds. Blood samples were taken before and after 20 days intervention. Disease activity score and gastrointestinal symptoms were evaluated using the Mayo score and gastrointestinal symptom rating scale (GSRS) respectively.

Results: Erythrocyte sedimentation rate (p = 0.03) and high-sensitivity C-reactive protein (p < 0.001) were decreased significantly after EVOO consumption. Bloating, constipation, fecal urgency, incomplete defecation, and final GSRS were reduced significantly after EVOO consumption (p < 0.05).

Conclusions: Intake of EVOO decreased the inflammatory markers and improved gastrointestinal symptoms in UC patients. It seems this functional food can be beneficial in the treatment of UC as a complementary medicine.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Colitis, Ulcerative / blood
  • Colitis, Ulcerative / diet therapy*
  • Colitis, Ulcerative / pathology
  • Colitis, Ulcerative / physiopathology*
  • Complementary Therapies
  • Cross-Over Studies
  • Female
  • Functional Food*
  • Humans
  • Male
  • Olive Oil / pharmacology*
  • Olive Oil / therapeutic use*
  • Rapeseed Oil / pharmacology*
  • Rapeseed Oil / therapeutic use*

Substances

  • Biomarkers
  • Olive Oil
  • Rapeseed Oil